Home / Inspections / 1216119

FDA Inspection 1216119 — Alcresta Therapeutics, Inc.

Alcresta Therapeutics, Inc. — FEI 3009596666

The FDA completed an inspection of Alcresta Therapeutics, Inc. on August 16, 2023 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Waltham, MA (United States)

Facility

Other inspections at this facility

  • 1153712 (NAI Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1037963 (NAI Mon Jan 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources